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Abstract
We use optical tweezers to perform stretching experiments on DNA molecules when interacting
with the drugs daunomycin and ethidium bromide, which intercalate the DNA molecule. These
experiments are performed in the low-force regime from zero up to 2 pN. Our results show that
the persistence length of the DNA-drug complexes increases strongly as the drug concentration
increases up to some critical value. Above this critical value, the persistence length decreases
abruptly and remains practically constant for larger drug concentrations. The contour length of
the molecules increases monotonically and saturates as drugs concentration increases. Measured in-
tercalants critical concentrations for the persistence length transition coincide with reported values
for the helix-coil transition of DNA-drug complexes, obtained from sedimentation experiments.
Key words: DNA; daunomycin; ethidium bromide; persistence length; optical tweezers; single
molecule
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I. INTRODUCTION
DNA-drug interactions have been much studied along the past years. An important
motivation for these studies is the fact that many of the studied drugs are used for treatment
of human diseases, particularly, in cancer chemotherapy.
Single molecule stretching experiments using optical tweezers have yielded a great amount
of information about DNA-protein and DNA-drug interactions [1, 2, 3, 4, 5, 6].
Recently, we studied the interaction between psoralen and DNA when illuminated with
ultraviolet light A (UVA). Psoralen is a drug used to treat some skin diseases, like psoriasis
and vitiligo. This drug intercalates the DNA molecule and can form covalent linkages with
the thymines if the complex is illuminated with ultraviolet light, modifying drastically its
elasticity and impeding the DNA replication and transcription. The persistence length of
the DNA-psoralen complexes formed after UVA illumination were measured in [7].
Daunomycin and ethidium bromide (EtBr) are other examples of drugs which intercalate
the DNA molecule and can modify its elasticity, depending on the drug concentration. Both
drugs unwind the DNA double helix when intercalating [8]. Daunomycin is an anthracy-
cline antibiotic used in the treatment of various cancers. It inhibits DNA replication and
transcription when intercalating, impeding cell duplication [9]. Ethidium bromide (EtBr)
is commonly used as a non-radioactive marker for identifying and visualizing nucleic acid
bands in electrophoresis and in other methods of nucleic acid separation.
Several works have reported different results for the effects of these drugs on the entropic
elasticity of DNA molecules. In those works, the measured parameter used to study elasticity
modifications is the persistence length of the DNA-drug complex. Smith et al. [2] report
that ethidium bromide does not modify the elasticity of the DNA molecule, only increasing
its contour length by ∼40%. Tessmer et al. [10] report that ethidium bromide causes a large
increase in the contour length and a decrease in the persistence length of the complex for
1 µM of the drug, and at lower concentrations, an increase in both persistence and contour
lengths. Recently, Sischka et al. [11] report the value of 28.1 nm for the persistence length of
DNA-daunomycin complexes and 20.7 nm for DNA-EtBr complexes, smaller than the bare
DNA persistence length of about 50 nm. The authors have used in this work a concentration
of 1 µM for both drugs, and a DNA concentration of 15 pM. In the present work, in order to
clearly establish the effect of these intercalating drugs on the persistence length of the DNA
2
complexes, we performed stretching experiments at various drugs concentrations, from zero
up to saturation of the complexes. We show that the values obtained for the persistence
length depend strongly on the concentration ratio between drug and DNA base pairs. Our
results show that the persistence length of the complexes increases as we increase the drug
concentration until certain critical concentration is reached. Above this critical concentration
the persistence length decreases abruptly and remains practically constant for larger drug
concentrations.
II. EXPERIMENTAL PROCEDURE
To measure the persistence and contour length of DNA molecules and DNA-drug com-
plexes, we use optical tweezers [1, 2, 3, 4, 5, 6] and intensity autocorrelation spectroscopy
[12].
The samples consist of λ-DNA molecules in a PBS pH 7.4 with [NaCl] = 140 mM solution.
We attach one end of the molecule to a microscope coverslip, and the other end is attached
to a polystyrene bead. To do this, we use the procedure described in [13]. We add the drug
in the sample immediately before the measurements. The DNA concentration used in all
experiments was CDNA = 6.81 µg/mL, which corresponds to a base pairs concentration of
Cbp = 11 µM.
Our optical tweezers is mounted in a Nikon TE300 microscope with an infinite corrected
objective (100X, N.A. = 1.4). The trapping laser is an infrared (IR) laser with λ = 832 nm
(SDL, 5422-H1). The optical tweezers is used to trap the polystyrene bead attached to the
end of the DNA molecule, so we can manipulate and stretch the DNA molecule.
In addition, we use a He-Ne laser (λ = 632.8 nm) as the scattering probe. The backscat-
tered light by the polystyrene bead is collected by a photodetector, which delivers pulses
to a digital correlator. We, then, obtain the autocorrelation function of the backscattered
light, which allows us to determine the stiffness of the optical trap, due to the Brownian
motion of the trapped bead.
The next step in the experimental procedure is to obtain the force versus extension curves
for the DNA molecules and DNA-drug complexes. To do this, we use the optical tweezers
to trap the bead with the DNA while pulling the microscope slide, stretching the DNA.
The backscattered light is collected while stretching the DNA. From the backscattered light
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intensity one obtains the displacement of the trapped bead in relation to its equilibrium
position, and by multiplying it times the tweezers’ stiffness, the force exerted by the DNA
molecule while it is stretched is obtained. The details about our experimental setup and
experimental procedure can be found in [7, 12].
Finally, with the force versus extension curves, we use the approximate expression derived
by Marko and Siggia (Eq. 1) [14] to obtain the persistence and contour length of the DNA
molecules and DNA-drug complexes,
F =
kBT
A
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+
1
4
(
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L
)
2
−
1
4

 , (1)
where z is the DNA molecule end-to-end distance, kB is the Boltzmann constant, T is the
absolute temperature, A is the DNA persistence length and L is the DNA contour length.
Figure 1 is a typical force versus extension curve obtained with this procedure, for a
drug-free DNA molecule. Fitting this curve with Eq. 1, we extract the persistence length
(A = 50 ± 3 nm) and the contour length (L = 16.5 ± 1 µm) for the λ-DNA. These values
correspond to well-known values reported in the literature [3, 15, 16].
III. RESULTS AND DISCUSSION
In this section we show the results obtained for the two drugs used: daunomycin and
ethidium bromide.
A. Daunomycin
We have performed experiments with DNA-daunomycin complexes for several drug con-
centrations. In Fig. 2 we show the persistence length (A) of the complexes as a function
of total daunomycin concentration (CD) for fixed DNA base pairs concentration of Cbp =
11 µM. We denote by CD the total daunomycin concentration used to prepare the sample,
which is the sum of both the bounded to DNA and the free drug concentration in solution.
The point which the drug concentration is zero corresponds to the drug-free DNA situa-
tion with A = 50 nm.
The behavior of the persistence length A as a function of daunomycin concentration CD
can be described as follows: it initially increases with CD until it reaches a maximum value
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(∼ 280 nm) at the critical concentration CcriticalD = 18.3 µM. Then, it decays abruptly to
around 75 nm and remains practically constant at this value even if we continue to increase
CD. The contour length increases monotonically from 16.5 ± 1 µm up to the saturation
value of 21 ± 1 µm. These mean values are obtained performing an average over many
different DNA molecules and DNA-drug complexes. Such distribution of contour length
values was also observed by Mihailovic et al. [17].
Also, we can estimate the exclusion parameter n (number of total base pairs divided by
the number of total intercalated drug molecules) from our experimental data. The average
value of the contour length for DNA-daunomycin complexes obtained when using a saturated
concentration of the drug increases about 27% relative to drug-free DNA contour length
(16.5 µm). This means that when all possible drug molecules are intercalated, the DNA
increases its contour length by 4.5 µm. Knowing that each intercalated daunomycin molecule
increases the contour length of the complex by 0.31 nm [8], we determine the total number of
intercalated daunomycin molecules, which is around 14500. Finally, the exclusion parameter
can be obtained by dividing the number of base pairs of the λ-DNA (48500) by the number
of total intercalated drug molecules (14500). We obtain n = 3.3, in good agreement with
the value 3.5 reported in [9].
For comparison purposes, Fig. 3 shows two force versus extension curves (normalized by
the contour length) for two daunomycin concentrations, before and after the transition. The
data points in this figure are smoothed for better visualization, i. e., Brownian fluctuations
are averaged out.
B. Ethidium Bromide (EtBr)
The behavior of the persistence length as a function of the drug concentration for DNA-
EtBr complexes is very similar to the DNA-daunomycin complexes. The difference is that in
this case the transition occurs at a lower drug concentration (see Fig. 4) for the same DNA
base pairs concentration Cbp = 11 µM. The maximum value measured for the persistence
length of DNA-EtBr complexes is ∼ 150 nm, at the critical concentration CcriticalE = 3.1 µM.
The contour length increases monotonically from 16.5 ± 1 µm up to the saturation value
of 23 ± 1 µm. Again, these values for the contour lengths are averages over many different
molecules.
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Repeating the same calculation for the exclusion parameter of EtBr, which increases
the DNA contour length by 0.34 nm per intercalated molecule [11], we obtain n = 2.5, in
reasonable agreement with the value 2.01 reported in [18].
C. Equilibrium binding constants
In our experiments we control the total drug concentration CT and the total concentration
of DNA base pairs Cbp. To discuss the elastic properties of the DNA complex formed the
important parameter to consider is the ratio r between the concentration of bounded drug
(Cb) per concentration of DNA base pairs (Cbp). In order to obtain r, the binding of molecules
to DNA is analyzed using the neighbor exclusion model [9]. A closed form for this model
was obtained by McGhee and von Hippel [19] and can be expressed by the equation
r
Cf
= Ki(1− nr)
[
1− nr
1− (n− 1)r
]n−1
, (2)
where r is ratio between the concentration of bounded drug (Cb) per concentration of DNA
base pairs (Cbp), Cf is the concentration of free drug (not bounded), Ki is the intrinsic bind-
ing constant and n is the exclusion parameter in base pairs. For a more detailed discussion
about the neighbor exclusion model, see [19].
The concentration of free drug (Cf) can be simply related with the concentration of
bounded drug (Cb) and the total drug concentration (CT ) through the equation
CT = Cf + Cb. (3)
Using Eq. 2 and 3 with the determined exclusion parameter (n = 3.3), the intrinsic
binding constant reported in [9] for daunomycin, Ki = 7×10
5 M−1, the critical daunomycin
concentration measured in this work (CcriticalD = 18.3 µM), and the concentration of DNA
base pair used in our experiments (Cbp = 11 µM), we can determine the critical ratio rc,
which we define as the value of r at the abrupt transition for the value of the persistence
length. We then obtain the value rc = 0.248.
Similarly, for EtBr, we use the parameters n = 2.5, Ki = 1.5×10
5 M−1 [20], and CcriticalE
= 3.1 µM determined again from the abrupt change in persistence length. We obtain rc =
0.131. In Section IIID we compare the values obtained for rc with those reported in the
literature for a sedimentation experiment.
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It is important to mention that Ki varies with the ionic strength of the solution. The
values used here are the values for the ionic concentrations used in our experiments.
D. Interpretation of the DNA-drug complexes elasticity results
For low drug concentrations, drug intercalation in the DNA molecule increases the rigidity
of the complex (see Figs. 2 and 4). This is consistent with the results of Vladescu et al. [21],
which shows that EtBr stabilizes the DNA double-helix for low drug concentrations. They
have performed melting experiments with various EtBr concentrations, from zero to 2.5 µM,
showing that EtBr intercalation stabilizes the DNA double-helix in this concentration range.
Therefore, we expect an increase of the persistence length of DNA-drug complexes in this
low concentration range. Figure 4 shows this increase for EtBr, and Fig. 2 shows a similar
result for daunomycin.
For high drug concentrations, i. e., above the critical concentration (peak of Figs. 2 and
4), the persistence length of the complexes decays abruptly and remains practically constant.
It is well-known that intercalation unwinds the DNA double-helix [8]. Due to unwinding
and above some drug critical concentration, the complexes can have a helix-coil transition,
which can cause DNA denaturing as the DNA is stretched, decreasing the persistence length
of DNA-drug complexes as seen in Figs. 2 and 4. The unwinding angle per intercalated EtBr
drug molecule is approximately 1.7 times greater than that for daunomycin intercalation [8].
Therefore we expect that the transition occurs for EtBr at a lower drug concentration as
compared with daunomycin, if the same DNA concentration is used. This is confirmed
experimentally in our data of Figs. 2 and 4.
Sedimentation experiments performed with circular DNA as a function of daunomycin
and ethidium bromide concentrations display a minimum in the sedimentation coefficient
S20 at rc = 0.192, for daunomycin and rc = 0.114 for ethidium bromide [8]. The minimum in
the sedimentation coefficient S20 is associated with a helix-coil transition, due to unwinding
of the DNA double-helix by the intercalating drugs [8]. These numbers agree within 15 to
30% with the values of rc determined from our DNA persistence length measurements. This
indicates that the abrupt change of the DNA persistence length for both drugs might be
also caused by a helix-coil transition due to the unwinding of the DNA double-helix as the
drugs intercalate into it. The reasonable agreement between the critical ratios rc obtained
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from sedimentation experiments [8] and from our measurements of the persistence length
transition provides an evidence that a helix-coil transition is probably what we are observing
in our experiments.
In addition, it is known that EtBr (and also most intercalating drugs) exhibits multi-
modality at their interaction with DNA [22, 23]. The type of interaction varies with the
drug concentration. The abrupt transition shown in Figs. 2 and 4 might as well be caused
by different ways of drug binding to DNA.
IV. CONCLUSION
We have made systematic measurements of the entropic elasticity variation of a λ-DNA
molecule when interacting with two drugs, daunomycin and ethidium bromide, as a function
of their concentrations. Our results show that the persistence length of the DNA-drug
complexes increases strongly as the drug concentration increases, for low concentrations.
Above certain critical drug concentration the persistence length decreases abruptly and
remains practically constant for high drug concentrations. This behavior is quite similar
for both daunomycin and EtBr, as shown in Figs. 2 and 4. Our results suggests that the
abrupt transition observed in the persistence length might be due to a helix-coil transition
and denaturing of DNA-drug complexes above the critical concentration, resulting in a
decrease of the persistence length.
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Figure Legends
Figure 1.
Force as a function of extension for a drug-free DNA molecule. By fitting this curve with
Eq. 1, we determine the persistence length A = 50 ± 3 nm and the contour length L = 16.5
± 1 µm.
Figure 2.
Persistence length A of DNA-daunomycin complexes as a function of drug concentration
for fixed DNA concentration (Cbp = 11 µM). A initially increases with CD until it reaches
a maximum value (∼ 280 nm) at the critical concentration CcriticalD = 18.3 µM. Then, the
persistence length decays abruptly to around 75 nm and remains practically constant at this
value even if we continue to increase the drug concentration.
Figure 3.
Force versus extension curves (normalized by the contour length) for two daunomycin
concentrations. The data Brownian fluctuations are averaged out for better visualization.
Circles : CD = 20.1 µM (above the critical concentration) and A ∼ 61 nm; triangles : CD =
18.3 µM and A ∼ 263 nm. Dashed lines are fittings using Eq. 1.
Figure 4.
Persistence length of DNA-EtBr complexes as a function of drug concentration for fixed
DNA concentration (Cbp = 11 µM). Here, the transition occurs at a lower drug concentration.
The maximum value measured for the persistence length of DNA-EtBr complexes is ∼ 150
nm, at the critical concentration CcriticalE = 3.1 µM.
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